Apertura Gene Therapy

Apertura is a biotechnology company opening opportunities in gene therapy for treating debilitating diseases with limited options. We are pioneering next-generation AAV gene therapies by simultaneously engineering capsids, regulatory elements, and payloads to overcome current limitations in genetic medicine. Founded on technologies from the Broad Institute and Harvard University, and with support from Deerfield Management Company, we are located at the Cure in New York City

Apertura gene therapy operates in the Biotechnology research industry.

Apertura gene therapy's revenue is 11m - 100m

Apertura gene therapy has 11 - 50 employees.